Great News!
We are delighted to announce that our manufacturing facility in Matoda – Ahmedabad has successfully renewed its ANVISA GMP certification, extending it until September 2025. Following a rigorous audit conducted by regulatory agency representatives from Brazil, our site received official approval for this process on September 11th. This accomplishment underscores our unwavering dedication to delivering pharmaceuticals of the utmost quality standards to Brazil and international markets.
We extend our heartfelt congratulations to all the teams involved, not only in the audit process but also in the daily efforts that ensure our sites consistently produce high-quality and cost-effective medications. Your dedication and commitment are truly commendable.
